Performance evaluation of the new roche cobas ampliprep/cobas taqman HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1195-1200

  Pas, Suzan ^a   Rossen, John W A ^b   Schoener, Daniel ^c   Thamke, Diana ^c   Pettersson, Annika ^d   Babiel, Reiner ^c   Schutten, Martin ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CPRLab   (Netherlands)

^c Roche Molecular Systems   (Switzerland)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ABBOTT M2000 REALTIME HIV 1 ASSAY; ARTICLE; BLOOD SAMPLING; COBAS AMPLICOR HIV 1 MONITOR TEST; COBAS AMPLIPREP COBAS TAQMAN HIV 1 TEST; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG TREATMENT FAILURE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; ROCHE COBAS AMPLIPREP COBAS TAQMAN HIV 1 TEST; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; VIRUS LOAD; VIRUS REPLICATION;

HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 77950502841     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01832-09     Document Type: Article

References (23)

1. Abbott, M. A., B. J. Poiesz, B. C. Byrne, S. Kwok, J. J. Sninsky, and G. D. Ehrlich. 1988. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis. 158: 1158-1169.
2. Aberg, J. A., J. E. Kaplan, H. Libman, P. Emmanuel, J. R. Anderson, V. E. Stone, J. M. Oleske, J. S. Currier, and J. E. Gallant. 2009. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis. 49: 651-681.
3. Compton, J. 1991. Nucleic acid sequence-based amplification. Nature 350: 91-92.
4. de Baar, M. P., M. W. van Dooren, E. de Rooij, M. Bakker, B. van Gemen, J. Goudsmit, and A. de Ronde. 2001. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1. isolates from groups M, N, and O. J. Clin. Microbiol. 39: 1378-1384.
5. Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevachari, R. T. Davey, Jr., J. A. Kovacs, N. P. Salzman, H. C. Lane, and M. S. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170: 1172-1179.
6. Gatanaga, H., K. Tsukada, H. Honda, J. Tanuma, H. Yazaki, T. Watanabe, M. Honda, K. Teruya, V. Kikuchi, and S. Oka. 2009. Detection of HIV type 1. load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor. Clin. Infect. Dis. 48: 260-262.
7. Gueudin, M., J. C. Plantier, V. Lernet, M. P. Schmitt, L. Chartier, T. Bourlet, A. Ruffault, F. Damond, M. Vray, and F. Simon. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44: 500-505.
8. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6: 986-994.
9. Holmes, H., C. Davis, and A. Heath. 2008. Development of the 1st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acidbased techniques. J. Virol. Methods 154: 86-91.
10. 10. Holmes, H., C. Davis, A. Heath, I. Hewlett, and N. Lelie. 2001. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J. Virol. Methods 92: 141-150. (Pubitemid 32171982)
11. Kievits, T., B. van Gemen, D. van Stryp, R. Schukkink, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35: 273-286.
12. Korn, K., B. Weissbrich, C. Henke-Gendo, A. Helm, C. M. Jauer, N. Taylor, and J. Eberle. 2009. Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay. J. Clin. Microbiol. 47: 1238-1240.
13. Lima, V., R. Harrigan, and J. S. Montaner. 2009. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J. Acquir. Immune Defic. Syndr. 51: 3-6.
14. Manavi, K. 2008. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5. HIV Clin. Trials 9: 283-286.
15. Menzo, S., P. Bagnarelli, M. Giacca, A. Manzin, P. E. Varaldo, and M. Clementi. 1992. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J. Clin. Microbiol. 30: 1752-1757.
16. Murphy, D. G., L. Cote, M. Fauvel, P. Rene, and J. Vincelette. 2000. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with. Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 38: 4034-4041.
17. Schumacher, W., E. Frick, M. Kauselmann, V. Maier-Hoyle, R. van der Vliet, and R. Babiel. 2007. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J. Clin. Virol. 38: 304-312.
18. Schutten, M., E. Fries, C. Burghoorn-Maas, and H. G. Niesters. 2007. Evaluation of the analytical performance of the new Abbott RealTime RTPCRs for the quantitative detection, of HCV and HIV-1 RNA. J. Clin. Virol. 40: 99-104.
19. Schutten, M., and H. G. Niesters. 2001. Clinical utility of viral quantification as a tool for disease monitoring. Expert Rev. Mol. Diagn. 1: 153-162.
20. Schutten, M., D. Peters, N. K. Back, M. Beld, K. Beuselinck, V. Foulongne, A. M. Geretti, L. Pandiani, C. Tiemann, and H. G. Niesters. 2007. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1. and hepatitis C virus RNA. J. Clin. Microbiol. 45: 1712-1717.
21. 21. Schutten, M., B. van den Hoogen, M. E. van der Ende, R. A. Gruters, A. D. Osterhaus, and H. G. Niesters. 2000. Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma. J. Virol. Methods 88: 81-87. (Pubitemid 30642845)
22. Smit, E., S. Bhattacharya, H. Osman, and S. Taylor. 2009. Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay. J. Acquir. Immune Defic. Syndr. 51: 364-365.
23. Yao, J. D., J. J. Germer, F. Damond, B. Roquebert, and D. Descamps. 2008. Plasma load discrepancies between the Roche Cobas Amplicor human immunodeficiency virus type 1 (HIV-1) Monitor version .1.5 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assays. J. Clin. Microbiol. 46: 834.